Applies to oritavancin: intravenous powder for solution
As well as its needed effects, oritavancin may cause unwanted side effects that require medical attention. 

If any of the following side effects occur while taking oritavancin, check with your doctor or nurse immediately:
Some oritavancin side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to oritavancin: intravenous powder for injection
In pooled clinical trials, serious side effects were reported in 5.8% of patients treated with this drug (compared to 5.9% treated with vancomycin).  Cellulitis was the serious side effect reported most often with both drugs.  The most common side effects reported in patients treated with this drug were headache, nausea, vomiting, limb and subcutaneous abscesses, and diarrhea.  This drug was discontinued due to side effects in 3.7% of patients; most often due to cellulitis and osteomyelitis.[Ref]
Common (1% to 10%): Nausea, vomiting, diarrheaFrequency not reported: Clostridium difficile associated diarrhea[Ref]
Common (1% to 10%): Headache, dizziness[Ref]
Common (1% to 10%): Infusion site phlebitis, infusion site reaction, abscess (limb and subcutaneous)Frequency not reported: Infusion related reactions (including pruritus, urticaria, flushing), osteomyelitis, infusion site erythema, extravasation, induration, peripheral edema[Ref]
Common (1% to 10%): Increased ALT, increased ASTFrequency not reported: Increased total bilirubin[Ref]
Common (1% to 10%): Tachycardia[Ref]
Frequency not reported: Cellulitis, pruritus, rash, urticaria, angioedema, erythema multiforme, pruritus, leukocytoclastic vasculitis[Ref]
Frequency not reported: Hypersensitivity reactions[Ref]
Frequency not reported: Anemia, eosinophilia[Ref]
Frequency not reported: Hyperuricemia, hypoglycemia[Ref]
Frequency not reported: Tenosynovitis, myalgia[Ref]
Frequency not reported: Bronchospasm, wheezing[Ref]
1. "Product Information. Orbactiv (oritavancin)." The Medicines Company, Parsippany, NJ. 
It is possible that some side effects of oritavancin may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Changes in skin color
dry, red, hot, or irritated skin
fast, pounding, or irregular heartbeat or pulse
pain, swelling, or tenderness in the skin


Black, tarry stools
blistering, peeling, or loosening of the skin
fever
hives, itching skin, or rash
increase in bone pain
joint pain, stiffness, or swelling
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
redness, soreness, or itching skin
sores, welting, or blisters
swelling of the eyelids, face, lips, hands, or feet
swollen glands
tightness in the chest
unusual bleeding or bruising


Abdominal or stomach tenderness
severe abdominal or stomach cramps and pain
watery and severe diarrhea, which may also be bloody


Dizziness
headache
nausea or vomiting

